Patents by Inventor Michael R. Myers

Michael R. Myers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190376259
    Abstract: A work vehicle includes a torque converter having a lock up clutch and a controller that conditionally allows operation of the lock up clutch in a locked position or an unlocked position. The controller determines a plurality of active work vehicle parameters during operation of the work vehicle and includes a plurality of ready to dig parameters. The controller determines a ready to dig condition or a non-digging condition of the work vehicle by comparing at least two of the active work vehicle parameters to at least two corresponding ready to dig parameters. The controller disallows operation of the lock up clutch in the locked position in response to the ready to dig condition, allows operation of the lock up clutch in locked or unlocked positions in response to a non-digging condition. Operation of the lock up clutch avoids the engine from stalling in a ready to dig condition.
    Type: Application
    Filed: June 8, 2018
    Publication date: December 12, 2019
    Inventors: Megan L. Pence, Kevin W. Campbell, David J. Myers, Kyle E. Leinaar, Thomas A. Porter, Michael R. Goodpaster
  • Patent number: 10499669
    Abstract: Composition having a blue color including a buffer, an anthocyanin, and a divalent ion source. The composition may comprise an anthocyanin and a divalent ion source, wherein the average variation of ?E*ab of the composition is less than 30% of the average variation of ?E*ab of a control composition after exposure of the composition and the control composition to a 400 to 765 W/m2 light source for a period of time. The composition may comprise an anthocyanin and a divalent ion source, wherein the composition exhibits a less than 20% change in the area beneath the reflectance colorimeter spectral curve of the composition from 430 nm to 530 nm measured over a period of time. In another aspect, a method of stabilizing a blue colorant is provided. The method may comprise combining a buffer, an anthocyanin, and a divalent ion source.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: December 10, 2019
    Assignee: Sensient Colors LLC
    Inventors: Gale D. Myers, Michael C. Jelavich, Leo H. Otto, Jeffrey R. Plodzien
  • Patent number: 10494738
    Abstract: A method of growing crystalline materials on two-dimensional inert materials comprising functionalizing a surface of a two-dimensional inert material, growing a nucleation layer on the functionalized surface, and growing a crystalline material. A crystalline material grown on a two-dimensional inert material made from the process comprising functionalizing a surface of a two-dimensional inert material, growing a nucleation layer on the functionalized surface, and growing a crystalline material.
    Type: Grant
    Filed: January 28, 2019
    Date of Patent: December 3, 2019
    Assignee: The Government of the United States of America, as represented by the Secretary of the Navy
    Inventors: Neeraj Nepal, Virginia Wheeler, Charles R. Eddy, Jr., Francis J. Kub, Travis J. Anderson, Michael A. Mastro, Rachael L. Myers-Ward, Sandra C. Hangarter
  • Publication number: 20190362612
    Abstract: A system that stores a user profile that associates a wearable alert device with a user and includes contact information for an emergency contact, receives information indicative of a real-time location of the wearable alert device and information indicating that the user of the wearable alert device is potentially experiencing an abnormal physiological condition, and outputs an alert for transmittal to the emergency contact that includes an indication that the user is potentially experiencing the abnormal physiological condition and the real-time location of the wearable alert device.
    Type: Application
    Filed: August 6, 2019
    Publication date: November 28, 2019
    Inventors: Joel N. Myers, Lachlan Myers, Michael R. Root, Michael R. Smith
  • Publication number: 20190362611
    Abstract: A system that stores information indicative of real-time locations of a wearable alert devices, receives information indicative of a potentially dangerous condition in a geographic area, determines which of the wearable alert devices are in the geographic area, and outputs alerts for transmittal to the wearable alert devices in the geographic area.
    Type: Application
    Filed: August 6, 2019
    Publication date: November 28, 2019
    Inventors: Joel N. Myers, Lachlan Myers, Michael R. Root, Michael R. Smith
  • Patent number: 10417893
    Abstract: In one embodiment, a system that stores information indicative of real-time locations of a wearable alert devices, receives information indicative of a potentially dangerous condition in a geographic area, determines which of the wearable alert devices are in the geographic area, and outputs alerts for transmittal to the wearable alert devices in the geographic area. In another embodiment, the system stores a user profile that associates a wearable alert device with a user and includes contact information for an emergency contact, receives information indicative of a real-time location of the wearable alert device and information indicating that the user of the wearable alert device is potentially experiencing an abnormal physiological condition, and outputs an alert for transmittal to the emergency contact that includes an indication that the user is potentially experiencing the abnormal physiological condition and the real-time location of the wearable alert device.
    Type: Grant
    Filed: January 4, 2017
    Date of Patent: September 17, 2019
    Assignee: LOCATOR IP, L.P.
    Inventors: Joel N. Myers, Lachlan Myers, Michael R. Root, Michael R. Smith
  • Publication number: 20190249395
    Abstract: A work machine having a cab coupled to a frame, a steering system coupled to the frame, a controller configured to selectively articulate the steering system, a joystick assembly positioned in the cab and in communication with the controller, a steering wheel assembly positioned in the cab and configured to selectively articulate the steering system, and a steering wheel sensor coupled to the steering wheel assembly and in communication with the controller to identify movement of the steering wheel assembly. Wherein, the controller does not articulate the steering system responsive to movement of the joystick assembly when the steering wheel sensor identifies movement of the steering wheel.
    Type: Application
    Filed: February 13, 2018
    Publication date: August 15, 2019
    Inventors: David J. Myers, Brian K. Kellogg, Aaron R. Kenkel, Adam J. Sobkowiak, Michael McCabe, Bryan J. Huttenlocher, Jason L. Mueller
  • Publication number: 20190208771
    Abstract: Improved aqueous herbicidal gel compositions comprising at least one water-soluble herbicide and a gel forming agent are provided. The gel compositions are particularly useful in increasing the loading of the water-soluble agrochemical salt, maximizing agrochemical uptake and/or translocation into treated plants and minimizing agrochemical loss to the environment. Methods for confined application of the gel compositions to control the growth of unwanted plants are also disclosed.
    Type: Application
    Filed: August 9, 2017
    Publication date: July 11, 2019
    Applicant: Monsanto Technology LLC
    Inventors: Eve De Maesschalck, Michael P. Myers, Daniel R. Wright
  • Publication number: 20190161887
    Abstract: A method of growing crystalline materials on two-dimensional inert materials comprising functionalizing a surface of a two-dimensional inert material, growing a nucleation layer on the functionalized surface, and growing a crystalline material. A crystalline material grown on a two-dimensional inert material made from the process comprising functionalizing a surface of a two-dimensional inert material, growing a nucleation layer on the functionalized surface, and growing a crystalline material.
    Type: Application
    Filed: January 28, 2019
    Publication date: May 30, 2019
    Applicant: The Government of the United States of America, as represented by the Secretary of the Navy
    Inventors: Neeraj Nepal, Virginia Wheeler, Charles R. Eddy, JR., Francis J. Kub, Travis J. Anderson, Michael A. Mastro, Rachael L. Myers-Ward, Sandra C. Hangarter
  • Patent number: 8606418
    Abstract: A control system is provided. The control system comprises an electronic processor configured to control operation of at least one wind turbine. The control system further comprises at least one weather radar unit positioned proximate to the at least one wind turbine and configured to generate weather data. The electronic processor is configured to control the operation of the at least one wind turbine based on the weather data generated by the at least one weather radar unit.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: December 10, 2013
    Assignee: Rockwell Collins, Inc.
    Inventors: Michael R. Myers, Joseph J. Engler
  • Patent number: 7946010
    Abstract: A tool for installing irrigation barb emitters into irrigation tubing including a cradle handle and a punch handle, the cradle handle and the punch handle being arranged in a parallel relation and connected intermediate their ends at a center point. A cradle which receives irrigation tubing is included. A punch pin allows a user to punch holes in irrigation tubing as desired with a spring loaded body which removes the punch pin when it has been driven into irrigation tubing. A barb holder allows a user to install emitter barbs into irrigation tubing as desired. A barb remover allows removal of barbs from irrigation tubing as desired.
    Type: Grant
    Filed: August 12, 2010
    Date of Patent: May 24, 2011
    Assignee: EMC Industries LLC
    Inventors: Michael R. Myers, Stephanie DePascal
  • Patent number: 7741316
    Abstract: A method of treating or preventing Alzheimer's disease, Parkinson's Disease and/or schizophrenia, this method comprising administering to a patient in need of such treatment a compound of formula: in which R, R3 and R4 are as defined in the specification.
    Type: Grant
    Filed: November 12, 2004
    Date of Patent: June 22, 2010
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Patent number: 7612075
    Abstract: This invention is directed to oxoazaheterocycyl compounds which inhibit Factor Xa, to oxoazaheterocycyl compounds which inhibit both Factor Xa and Factor IIa, to pharmaceutical compositions comprising these compounds, to intermediates useful for preparing these compounds, to a method of directly inhibiting Factor Xa and to a method of simultaneously directly inhibiting Factor Xa and Factor IIa.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: November 3, 2009
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: William R. Ewing, Michael R. Becker, Yong Mi Choi-Sledeski, Heinz W. Pauls, Wei He, Stephen M. Condon, Roderick S. Davis, Barbara A. Hanney, Alfred P. Spada, Christopher J. Burns, John Z. Jiang, Michael R. Myers, Wan F. Lau, Aiwen Li, Gregory B. Poli, Mark A. Bobko, Robert L. Morris, Joseph M. Karpinski, Timothy F. Gallagher, Kent W. Neuenschwander, Robert D. Groneberg, Jean-Francois Sabuco
  • Patent number: 7550597
    Abstract: This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor tyrosine kinase and/or Lck tyrosine kinase, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
    Type: Grant
    Filed: January 25, 2005
    Date of Patent: June 23, 2009
    Assignee: Aventis Pharmaceuticals, Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Paul E. Persons, Martin P. Maguire
  • Patent number: 7265111
    Abstract: The present invention relates to compounds according to the general formula (I) wherein X is selected from the group consisting of wherein n and p are independently 0, 1, 2, or 3, provided that n+p is a least 1; and unsubstituted and at least monosubstituted C1-C10-alkylene-Y, C2-C10-alkylene-Y, C3-C10-cycloalkylene-Y and C3-C10-cycloalkenylene-Y; and R1, A, B, Q, T, Y, E and W have the meanings given in the description. These compounds are useful for the manufacture of a medicament for the treatment of insulin resistance, type 2 diabetes, metabolic syndrome, lipid disorders or cardiovasular disease or for providing an anti-lipolytic effect.
    Type: Grant
    Filed: June 27, 2003
    Date of Patent: September 4, 2007
    Assignee: Sanofi-Aventis Deutschland GmbH
    Inventors: Antony Bigot, Siegfried Stengelin, Gerhard Jaehne, Andreas Herling, Guenter Mueller, Franz Jakob Hock, Michael R Myers
  • Patent number: 7132414
    Abstract: The present invention relates to pharmaceutical compositions containing, as active ingredient, a compound of formula: in which R1 represents a radical —NHCOR4 or —N(R5)—Y—R6, Y is CO or SO2, R4 represents a radical -alk-SO2—R11, -alk-SO2—CH?CH—R11 or Het substituted with —SO2—R11 or a phenyl radical substituted with —SO2—R11 or -alk-SO2—R11, R5 represents a hydrogen atom or an alkyl radical, R6 represents a phenylalkyl, Het or Ar radical, to the novel derivatives of formula (I) and to their preparation, as well s to their use in treating various disorders of the nervous system.
    Type: Grant
    Filed: February 4, 2004
    Date of Patent: November 7, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Herve Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Patent number: 6872717
    Abstract: A method of treating or preventing obesity, this method comprising administering to a patient in need of such treatment an effective amount of a compound of formula in which R, R3 and R4 are as defined in the specification.
    Type: Grant
    Filed: September 12, 2002
    Date of Patent: March 29, 2005
    Assignee: Aventis Pharma S.A.
    Inventors: Daniel Achard, Hervé Bouchard, Jean Bouquerel, Bruno Filoche, Serge Grisoni, Augustin Hittinger, Michael R. Myers
  • Patent number: 6852712
    Abstract: This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
    Type: Grant
    Filed: February 4, 2003
    Date of Patent: February 8, 2005
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Michael R. Myers, Wei He, Alfred P. Spada, Martin P. Maguire
  • Patent number: 6846815
    Abstract: This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor tyrosine kinase and/or Lck tyrosine kinase, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
    Type: Grant
    Filed: February 3, 2003
    Date of Patent: January 25, 2005
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Michael R. Myers, Alfred P. Spada, Paul E. Persons, Martin P. Maguire
  • Patent number: 6821962
    Abstract: This invention is directed to quinoline/quinoxaline compounds which inhibit platelet-derived growth factor or p56lck tyrosine kinase activity, to pharmaceutical compositions comprising these compounds, and to the use of these compounds for treating a patient suffering from or subject to disorders/conditions involving cellular differentiation, proliferation, extracellular matrix production or mediator release and/or T cell activation and proliferation.
    Type: Grant
    Filed: February 6, 2003
    Date of Patent: November 23, 2004
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Michael R. Myers, Wei He, Alfred P. Spada, Martin P. Maguire